Life sciences · Journal article
Frontiers in Immunology · October 5, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Cutaneous melanoma remains one of the most challenging neoplasms and the deadliest form of skin cancer. miRNAs are a class of non-coding RNA molecules found in both tissues and body fluids that can negatively regulate gene expression in eukaryotic cells, playing key roles in health and disease. Dysregulated miRNA levels have been linked to various aspects of melanocytic tumor biology, including the transition from benign to malignant stages, immunosuppression, dissemination, and therapy resistance. Here, we provide a timely review of the roles of miRNAs within the cutaneous melanoma tumor microenvironment, emphasizing their impact on immune cell phenotypes and functions, angiogenesis, innate and adaptive immunity, and immune checkpoint expression to help refine future biomarkers and therapeutic targets in the field. We will also address their roles in circular and long non-coding RNA sponging interactions and the potential for translating miRNAs into clinical practice, given their simultaneous presence in both cutaneous melanoma tissues and liquid biopsies. The main challenges and limitations associated with such a translational approach will also be addressed.